Undervalued Growth Potential

ERAMET is estimated to be undervalued based on cash flows, trading at €55.15 below its estimated future cash flow value of €63.34, representing a 12.9% discount. The company's earnings are forecast to grow significantly over the next three years, but debt coverage by operating cash flow remains a concern. Recent management changes and strategic reviews may influence Eramet's financial stability and operational recovery efforts.